These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 4400184)
1. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. Fitzgerald JD; O'Donnell SR Br J Pharmacol; 1971 Sep; 43(1):222-35. PubMed ID: 4400184 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the haemodynamic effects of propranolol, 4-hydroxypropranolol and practolol in anaesthetized dogs. Fitzgerald JD; O'Donnell SR Br J Pharmacol; 1972 Jun; 45(2):207-17. PubMed ID: 4403100 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Farmer JB; Kennedy I; Levy GP; Marshall RJ Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413 [TBL] [Abstract][Full Text] [Related]
4. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Bilski A; Robertson HH; Wale JL Clin Exp Pharmacol Physiol; 1979; 6(1):1-9. PubMed ID: 32980 [TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity. Giudicelli JF; Lhoste F Br J Clin Pharmacol; 1982; 13(Suppl 2):167S-174S. PubMed ID: 6125166 [TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A. Basil B; Jordan R; Loveless AH; Maxwell DR Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427 [TBL] [Abstract][Full Text] [Related]
7. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs. Boucher M; DuchĂȘne-Marullaz P; Moundanga JL Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587 [TBL] [Abstract][Full Text] [Related]
8. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs. Wale JL; Austin M; Conway J; Reeves M Clin Exp Pharmacol Physiol; 1979; 6(1):11-9. PubMed ID: 32981 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs. Muir WW; Sams RA; Schall SF J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
11. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Brittain RT; Levy GP Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948 [TBL] [Abstract][Full Text] [Related]
12. The selectivity of beta-adrenoceptor antagonists on isoprenaline-induced changes in heart rate, blood pressure, soleus muscle contractility and airways function in anaesthetized cats. Letts LG; Richardson DP; Temple DM; Williams LR Br J Pharmacol; 1983 Oct; 80(2):323-34. PubMed ID: 6140058 [TBL] [Abstract][Full Text] [Related]
13. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol. Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis. Whalen EJ; Bates JN; Johnson AK; Lewis SJ Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417 [TBL] [Abstract][Full Text] [Related]
15. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors. Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456 [TBL] [Abstract][Full Text] [Related]
16. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats. Parratt JR; Wadsworth RM Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541 [TBL] [Abstract][Full Text] [Related]
17. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity. Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacology of acebutolol in animals]. Basil B Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628 [TBL] [Abstract][Full Text] [Related]
19. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats. Ozawa H; Matsubara T; Chen CS Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631 [TBL] [Abstract][Full Text] [Related]
20. Selectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat. Apperley GH; Daly MJ; Levy GP Br J Pharmacol; 1976 Jun; 57(2):235-46. PubMed ID: 7334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]